Table 4

Relationship between flow-mediated dilation and inflammatory markers by race/ethnic group

Parameter and modelSpearman partial correlation coefficient
IL-6CRPTNF-α R1
Flow-mediated dilation %
Caucasian(n=1149)(n=1168)(n=423)
 Detectable correlation*0.0820.0820.136
  Univariate−0.091(0.002)0.055(0.06)−0.046(0.34)
  Multivariate†−0.016(0.60)0.046(0.11) 0.089(0.07)
  Multivariate‡−0.017(0.57)0.048(0.11) 0.045(0.37)
Chinese(n=624)(n=632)(n=581)
 Detectable correlation*0.1120.1110.116
  Univariate−0.102(0.01)−0.019(0.636)−0.123(0.003)
  Multivariate†−0.053(0.19)−0.014(0.727) 0.011(0.80)
  Multivariate‡−0.044(0.28)0.009(0.82) 0.044(0.30)
African American(n=754)(n=782)(n=349)
 Detectable correlation*0.1020.1000.149
  Univariate−0.068(0.07)0.018(0.62)−0.159(0.003)
  Multivariate†−0.044(0.23)−0.004(0.905)−0.088(0.10)
  Multivariate‡−0.039(0.31)−0.009(0.81)−0.117(0.040)
Hispanic(n=877)(n=899)(n=459)
 Detectable correlation*0.0940.0930.130
  Univariate−0.122(0.0003)0.003 (0.92)−0.086 (0.07)
  Multivariate†−0.064 (0.06)−0.031 (0.35)0.036 (0.44)
  Multivariate‡−0.062 (0.07)−0.012 (0.72)0.029 (0.55)
  • *Detectable correlation: the minimum of detectable absolute value of the correlation with the corresponding sample size with 80% power at a significance level of 0.05.

  • †Multivariate analysis adjusted for age and gender.

  • ‡Multivariate analysis included age, gender, education, income, low-density lipoprotein, glucose, diabetes, hypertension status and treatment, waist circumference, triglycerides, baseline brachial diameter and use of medications that may alter inflammation.

  • CRP, C reactive protein; IL-6, interleukin-6; TNF-α R1, tumour necrosis factor-α receptor 1.